Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.
Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. Pellegrini M, et al. Among authors: lindert k. Vaccine. 2009 Nov 16;27(49):6959-65. doi: 10.1016/j.vaccine.2009.08.101. Epub 2009 Sep 12. Vaccine. 2009. PMID: 19751689
Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009.
Tsai TF, Pedotti P, Hilbert A, Lindert K, Hohenboken M, Borkowski A, Groth N, da Silva LJ, Kyaw MH. Tsai TF, et al. Among authors: lindert k. Euro Surveill. 2010 Jul 29;15(30):19624. Euro Surveill. 2010. PMID: 20684814 Free article.
Trivalent and quadrivalent MF59(®)-adjuvanted influenza vaccine in young children: a dose- and schedule-finding study.
Della Cioppa G, Vesikari T, Sokal E, Lindert K, Nicolay U. Della Cioppa G, et al. Among authors: lindert k. Vaccine. 2011 Nov 3;29(47):8696-704. doi: 10.1016/j.vaccine.2011.08.111. Epub 2011 Sep 9. Vaccine. 2011. PMID: 21906647
Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study.
Bart S, Cannon K, Herrington D, Mills R, Forleo-Neto E, Lindert K, Abdul Mateen A. Bart S, et al. Among authors: lindert k. Hum Vaccin Immunother. 2016 Sep;12(9):2278-88. doi: 10.1080/21645515.2016.1182270. Epub 2016 Jun 20. Hum Vaccin Immunother. 2016. PMID: 27322354 Free PMC article. Clinical Trial.
Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial.
Hartvickson R, Cruz M, Ervin J, Brandon D, Forleo-Neto E, Dagnew AF, Chandra R, Lindert K, Mateen AA. Hartvickson R, et al. Among authors: lindert k. Int J Infect Dis. 2015 Dec;41:65-72. doi: 10.1016/j.ijid.2015.11.004. Epub 2015 Nov 14. Int J Infect Dis. 2015. PMID: 26585940 Free article. Clinical Trial.
A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.
Della Cioppa G, Nicolay U, Lindert K, Leroux-Roels G, Clement F, Castellino F, Galli C, Groth N, Levin Y, Del Giudice G. Della Cioppa G, et al. Among authors: lindert k. Hum Vaccin Immunother. 2014;10(6):1701-10. doi: 10.4161/hv.28618. Epub 2014 Apr 14. Hum Vaccin Immunother. 2014. PMID: 24732325 Free PMC article.
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults.
Della Cioppa G, Nicolay U, Lindert K, Leroux-Roels G, Clement F, Castellino F, Galli G, Groth N, Del Giudice G. Della Cioppa G, et al. Among authors: lindert k. Hum Vaccin Immunother. 2012 Feb;8(2):216-27. doi: 10.4161/hv.18445. Epub 2012 Feb 1. Hum Vaccin Immunother. 2012. PMID: 22426371 Clinical Trial.
Assessment of the safety, tolerability and kinetics of the immune response to A/H1N1v vaccine formulations with and without adjuvant in healthy pediatric subjects from 3 through 17 years of age.
Arguedas A, Soley C, Abdelnour A, Sales V, Lindert K, Della Cioppa G, Clemens R; Costa Rican H1N1 Vaccine Study Group. Arguedas A, et al. Among authors: lindert k. Hum Vaccin. 2011 Jan 1;7(1):58-66. doi: 10.4161/hv.7.1.13411. Epub 2011 Jan 1. Hum Vaccin. 2011. PMID: 21285531 Clinical Trial.
Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children and adults 65 years of age and older.
Lindert K, Leav B, Heijnen E, Barrett J, Nicolay U. Lindert K, et al. Int J Infect Dis. 2019 Aug;85S:S10-S17. doi: 10.1016/j.ijid.2019.03.020. Epub 2019 Mar 20. Int J Infect Dis. 2019. PMID: 30904674 Free article.
Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children.
Patel SS, Bizjajeva S, Lindert K, Heijnen E, Oberye J. Patel SS, et al. Among authors: lindert k. Int J Infect Dis. 2019 Aug;85S:S26-S38. doi: 10.1016/j.ijid.2019.05.009. Epub 2019 May 13. Int J Infect Dis. 2019. PMID: 31096055 Free article.
22 results
Jump to page
Feedback